fosphenytoin sodium
Generic: fosphenytoin sodium
Labeler: glenmark pharmaceuticals inc., usaDrug Facts
Product Profile
Brand Name
fosphenytoin sodium
Generic Name
fosphenytoin sodium
Labeler
glenmark pharmaceuticals inc., usa
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
fosphenytoin sodium 50 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
68462-945
Product ID
68462-945_2dead4d5-7696-4cf9-b8dc-5d10da310df3
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA214926
Listing Expiration
2027-12-31
Marketing Start
2025-05-28
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
68462945
Hyphenated Format
68462-945
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
fosphenytoin sodium (source: ndc)
Generic Name
fosphenytoin sodium (source: ndc)
Application Number
ANDA214926 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/mL
Packaging
- 10 VIAL, SINGLE-DOSE in 1 CARTON (68462-945-10) / 10 mL in 1 VIAL, SINGLE-DOSE (68462-945-64)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "2dead4d5-7696-4cf9-b8dc-5d10da310df3", "openfda": {"upc": ["0368462945643"], "unii": ["7VLR55452Z"], "rxcui": ["1670195"], "spl_set_id": ["bb38bc6a-99c7-4cda-b3f0-37f629d060cf"], "manufacturer_name": ["GLENMARK PHARMACEUTICALS INC., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (68462-945-10) / 10 mL in 1 VIAL, SINGLE-DOSE (68462-945-64)", "package_ndc": "68462-945-10", "marketing_start_date": "20250528"}], "brand_name": "Fosphenytoin sodium", "product_id": "68462-945_2dead4d5-7696-4cf9-b8dc-5d10da310df3", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68462-945", "generic_name": "Fosphenytoin sodium", "labeler_name": "GLENMARK PHARMACEUTICALS INC., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fosphenytoin sodium", "active_ingredients": [{"name": "FOSPHENYTOIN SODIUM", "strength": "50 mg/mL"}], "application_number": "ANDA214926", "marketing_category": "ANDA", "marketing_start_date": "20250528", "listing_expiration_date": "20271231"}